advertisement
Li K 30
Showing records 1 to 25 | Display all abstracts from Li K127694 Efficacy and Tolerability of Single-Dose Timolol Eye Drops in the Sequential Treatment of Acute Angle-Closure Crisis: A Double-Blind, Randomized, Placebo-Controlled Trial
Chen G
Clinical Therapeutics 2025; 47: 499-503
127965 Synergistic amelioration of glaucoma by exogenous BDNF supplementation and microRNA-93 inhibitors via regulating Rho/ROCK and BDNF/TrkB/CREB signaling pathways
Li K
Naunyn-Schmiedeberg's archives of pharmacology 2025; 398: 17845-17856
128856 Advanced Nanotechnology-Driven Innovations for Corneal Neovascularization Therapy: Smart Drug Delivery and Enhanced Treatment Strategies
Huang X
Advanced materials (Deerfield Beach, Fla.) 2025; 0: e2508726
127980 Ocular Hypertension or Glaucoma Risk Factor Prediction Models for Patients with Fuchs Uveitis Syndrome
Zhang X
Ocular Immunology and Inflammation 2025; 0: 1-9
127603 Preliminary evaluation on the effect of oral omega-3 supplementation from herring caviar oil in primary open-angle glaucoma patients
Luo J
International Ophthalmology 2025; 45: 305
127694 Efficacy and Tolerability of Single-Dose Timolol Eye Drops in the Sequential Treatment of Acute Angle-Closure Crisis: A Double-Blind, Randomized, Placebo-Controlled Trial
Wang J
Clinical Therapeutics 2025; 47: 499-503
127965 Synergistic amelioration of glaucoma by exogenous BDNF supplementation and microRNA-93 inhibitors via regulating Rho/ROCK and BDNF/TrkB/CREB signaling pathways
Long B
Naunyn-Schmiedeberg's archives of pharmacology 2025; 398: 17845-17856
128856 Advanced Nanotechnology-Driven Innovations for Corneal Neovascularization Therapy: Smart Drug Delivery and Enhanced Treatment Strategies
Wu Y
Advanced materials (Deerfield Beach, Fla.) 2025; 0: e2508726
127980 Ocular Hypertension or Glaucoma Risk Factor Prediction Models for Patients with Fuchs Uveitis Syndrome
Lu A
Ocular Immunology and Inflammation 2025; 0: 1-9
127603 Preliminary evaluation on the effect of oral omega-3 supplementation from herring caviar oil in primary open-angle glaucoma patients
Tu S
International Ophthalmology 2025; 45: 305
128856 Advanced Nanotechnology-Driven Innovations for Corneal Neovascularization Therapy: Smart Drug Delivery and Enhanced Treatment Strategies
Li K
Advanced materials (Deerfield Beach, Fla.) 2025; 0: e2508726
127980 Ocular Hypertension or Glaucoma Risk Factor Prediction Models for Patients with Fuchs Uveitis Syndrome
Pu Y
Ocular Immunology and Inflammation 2025; 0: 1-9
127603 Preliminary evaluation on the effect of oral omega-3 supplementation from herring caviar oil in primary open-angle glaucoma patients
Li K
International Ophthalmology 2025; 45: 305
127694 Efficacy and Tolerability of Single-Dose Timolol Eye Drops in the Sequential Treatment of Acute Angle-Closure Crisis: A Double-Blind, Randomized, Placebo-Controlled Trial
Li K
Clinical Therapeutics 2025; 47: 499-503
127965 Synergistic amelioration of glaucoma by exogenous BDNF supplementation and microRNA-93 inhibitors via regulating Rho/ROCK and BDNF/TrkB/CREB signaling pathways
Chen W
Naunyn-Schmiedeberg's archives of pharmacology 2025; 398: 17845-17856
127980 Ocular Hypertension or Glaucoma Risk Factor Prediction Models for Patients with Fuchs Uveitis Syndrome
Liu H
Ocular Immunology and Inflammation 2025; 0: 1-9
127603 Preliminary evaluation on the effect of oral omega-3 supplementation from herring caviar oil in primary open-angle glaucoma patients
Yang R
International Ophthalmology 2025; 45: 305
127965 Synergistic amelioration of glaucoma by exogenous BDNF supplementation and microRNA-93 inhibitors via regulating Rho/ROCK and BDNF/TrkB/CREB signaling pathways
Gan M
Naunyn-Schmiedeberg's archives of pharmacology 2025; 398: 17845-17856
128856 Advanced Nanotechnology-Driven Innovations for Corneal Neovascularization Therapy: Smart Drug Delivery and Enhanced Treatment Strategies
Xing W
Advanced materials (Deerfield Beach, Fla.) 2025; 0: e2508726
127965 Synergistic amelioration of glaucoma by exogenous BDNF supplementation and microRNA-93 inhibitors via regulating Rho/ROCK and BDNF/TrkB/CREB signaling pathways
Xu M
Naunyn-Schmiedeberg's archives of pharmacology 2025; 398: 17845-17856
128856 Advanced Nanotechnology-Driven Innovations for Corneal Neovascularization Therapy: Smart Drug Delivery and Enhanced Treatment Strategies
Zhao N
Advanced materials (Deerfield Beach, Fla.) 2025; 0: e2508726
127980 Ocular Hypertension or Glaucoma Risk Factor Prediction Models for Patients with Fuchs Uveitis Syndrome
Li K
Ocular Immunology and Inflammation 2025; 0: 1-9
127603 Preliminary evaluation on the effect of oral omega-3 supplementation from herring caviar oil in primary open-angle glaucoma patients
Lin Y
International Ophthalmology 2025; 45: 305
128856 Advanced Nanotechnology-Driven Innovations for Corneal Neovascularization Therapy: Smart Drug Delivery and Enhanced Treatment Strategies
Chen Z
Advanced materials (Deerfield Beach, Fla.) 2025; 0: e2508726
127980 Ocular Hypertension or Glaucoma Risk Factor Prediction Models for Patients with Fuchs Uveitis Syndrome
Su G
Ocular Immunology and Inflammation 2025; 0: 1-9
